GRACE

cancergrace.org

 

GRACE
J

Key Points From the ADAURA Trial: Osimertinib in NSCLC

By GRACE FEATURING Joshua Reuss
By GRACE FEATURING Joshua Reuss
77 views
February 13, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
Podcast Series
03:42
GRACE

The Importance of Prostate Cancer Screening

Feat. R. McKay
05:13
GRACE

Adding to Targeted Therapy in NSCLC: Current Statistics and Biology

Feat. P. Iyengar
07:49
GRACE

Local Therapy for Oligometastatic NSCLC Patients After Frontline The…

Feat. P. Iyengar
05:24
GRACE

Local Therapy for Patients With Oligoprogressive NSCLC

Feat. P. Iyengar
06:10
GRACE

Key Points From the ADAURA Trial: Osimertinib in NSCLC

Feat. J. Reuss
04:52
GRACE

The Importance of Biomarker Testing in NSCLC: What Is Liquid Biopsy?

Feat. A. Desai
03:22
GRACE

Barriers to Biomarker Testing: Cost and Insurance

Feat. A. Desai
03:06
GRACE

Neoadjuvant Treatment for Patients With NSCLC

Feat. J. Reuss
04:13
GRACE

Local Therapy for Limited mNSCLC

Feat. P. Iyengar